(2023) 15:e35625
Approved by the MHRA Because of the results of the trial, the UKs Medicines and Healthcare products Regulatory Agency (MHRA) has approved Wegovy as a treatment for preventing heart problems in overweight and obese adults with pre-existing cardiovascular disease
Please check with your local extension service to ensure registration status
These will reduce over time
All procedures in this study were performed after obtaining the required consent and following guidelines established by the Animal Care and Ethical Use Committee, Faculty of Veterinary Medicine, Cairo University, for the use of animals (Protocol: Vet CU20-09-2022-481)
Lv, Y., Liang, T., Wang, G., & Li, Z